Zobrazeno 1 - 10
of 353
pro vyhledávání: '"Joyce A, O'Shaughnessy"'
Autor:
Page E. Blas, Esther San Roman Rodriguez, Heather L. Williams, Maren K. Levin, Joshua S. K. Bell, Mariaelena Pierobon, Alexander S. Barrett, Emanuel F. Petricoin, Joyce A. O'Shaughnessy
Publikováno v:
Cancer Reports, Vol 7, Iss 3, Pp n/a-n/a (2024)
Abstract Background Overexpression of HER2 plays an important role in cancer progression and is the target of multiple therapies in HER2‐positive breast cancer. Recent studies have also highlighted the presence of activating mutations in HER2, and
Externí odkaz:
https://doaj.org/article/47960155bf034b2787b9b2901ca8c6f8
Autor:
Joyce Ann O'Shaughnessy
Publikováno v:
Baylor University Medical Center Proceedings. 17:168-184
Publikováno v:
Women's Health Weekly; 10/23/2023, p130-130, 1p
Autor:
Hope S. Rugo, Mario E. Lacouture, Marcus D. Goncalves, Umesh Masharani, Matti S. Aapro, Joyce A. O'Shaughnessy
Publikováno v:
Breast, Vol 61, Iss , Pp 156-167 (2022)
Purpose: The oral, α-specific phosphatidylinositol-3-kinase (PI3Kα) inhibitor alpelisib is the first PI3K inhibitor approved for the treatment of advanced breast cancer. As alpelisib is a relatively new therapeutic option, specific guidance and a m
Externí odkaz:
https://doaj.org/article/c6c4f39f76af47a99f7d292ece4d71d7
Autor:
PR Newswire
Publikováno v:
PR Newswire US. 10/10/2023.
Autor:
O'Shaughnessy, Joyce Ann
Publikováno v:
Baylor University Medical Center Proceedings; April 2004, Vol. 17 Issue: 2 p168-184, 17p
Autor:
Joyce A O'Shaughnessy, Jenny R Fox, Carlos A Encarnación, Brandon O'Neal, Kai Treuner, Tara Sanft, Rachel C Jankowitz, Mark D Pegram, Catherine A Schnabel, Sami G Diab
Publikováno v:
Cancer Research. 82:OT1-10
Background: Hormone receptor-positive (HR+) is the most common molecular subtype of breast cancer accounting for approximately 2 out of every 3 patients. Adjuvant anti-estrogen therapy is the cornerstone of systemic therapy, underscoring the critical
Autor:
Adam Brufsky, Hannah Linden, Hope Rugo, Charles Vogel, Joyce A O'Shaughnessy, Robert H Getzenberg, K. Gary Barnette, Domingo Rodriguez, Mitchell S Steiner, Erica Mayer
Publikováno v:
Cancer Research. 82:OT2-17
Targeting the androgen receptor (AR) may be the next important endocrine therapy for women with advanced breast cancer. AR is the most abundantly expressed steroid receptor in breast cancer and has been demonstrated to be a tumor suppressor when acti
Autor:
John D. Carpten, Daniel Von Hoff, Spyro Mousses, Jeffrey M. Trent, Anthony W. Tolcher, Bodour Salhia, Paul R. Billings, Linh Hoang, Asim Siddiqui, Francisco M. De La Vega, Onur Sakarya, Catalin Barbacioru, Julie Koeman, Angela Baker, Ahmet Kurdoglu, Tyler Izatt, Cynthia R. Osborne, Cristi L. Aitelli, Joanne L. Blum, Alexis Christoforides, Jennifer Dinh, Shukmei Wong, Tracy M. Moses, Shripad Sinari, Jessica Aldrich, Jeffrey A. Kiefer, Joyce A. O'Shaughnessy, David W. Craig
XLSX file - 23K, Mapping statistics for genome sequencing of tumor and germline DNA from mTNBC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35159989085fccfd12601538f787b088
https://doi.org/10.1158/1535-7163.22498339
https://doi.org/10.1158/1535-7163.22498339
Autor:
Anita Grigoriadis, Andrew N.J. Tutt, Christopher J. Lord, Joyce A. O'Shaughnessy, Melinda L. Telli, Maggie C.U. Cheang, Hasan Mirza, Jelmar Quist
Supplementary Figure S3: Molecular characterisation of the MC6 subtype in six TNBC cohorts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c794b682dd903af75bc5de2961e0acc
https://doi.org/10.1158/1535-7163.22504437.v1
https://doi.org/10.1158/1535-7163.22504437.v1